Acute respiratory distress syndrome: use of specialized nutrients in pediatric patients and infants.
With a high rate of mortality, acute respiratory distress syndrome (ARDS) has limited treatments options. Immune-enhanced formulas, containing eicosapentaenoic acid, borage oil, and antioxidants, have shown to be beneficial in adults patients with ARDS, decreasing mortality, length of mechanical ventilation, and new organ dysfunction. There is promising research in pediatric patients with improvement in oxygenation status found, but further trials are needed to realize these benefits in pediatric and infant populations.
Department of Pharmacy Practice, Auburn University Harrison School of Pharmacy, 1321 Walker Building, Auburn, AL 36849, USA. lah0010@auburn.edu
Leslie A
LA
Hamilton
Kimberly A
KA
Trobaugh
D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use*; D002648:Child; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D018529:Nutritional Support; D010938:Plant Oils / Q000627:therapeutic use*; D012128:Respiratory Distress Syndrome / Q000378:metabolism / Q000628:therapy*; D017965:gamma-Linolenic Acid / Q000627:therapeutic use*
D000975:Antioxidants; D010938:Plant Oils; D017965:gamma-Linolenic Acid; D015118:Eicosapentaenoic Acid; C079363:borage oil